What is Integra LifeSciences's total revenue?

Integra LifeSciences (IART) reported total revenue of $391.92M in Q1 2026.

How has Integra LifeSciences's total revenue changed year-over-year?

Integra LifeSciences's total revenue increased by 2.4% year-over-year, from $382.65M to $391.92M.

What is the long-term trend for Integra LifeSciences's total revenue?

Over 4 years (2021 to 2025), Integra LifeSciences's total revenue has grown at a 1.5% compound annual growth rate (CAGR), from $1.54B to $1.64B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Integra LifeSciences IART Total Revenue

Total Revenue at other companies

Becton, Dickinson and CompanyBDX

$4.71B+5.2%

StrykerSYK

$6.02B+2.6%

AxogenAXGN

$61.46M+26.6%

AbbVieABBV

$15B+12.4%

MedtronicMDT

$9.81B+9.9%

STERISSTE

$1.59B+7.3%

Segments

By product

See full

Neurosurgery$198.2M+3.8%

Wound Reconstruction$79.65M+6.5%

Instruments$47.23M-7.3%

ENT$37.71M-2.8%

Private Label$29.14M+7.1%

By geography

See full

Asia Pacific$45.21M+0.2%

Europe$39.96M+13.1%

Rest of World$17.36M-13.2%

By segment

See full

Specialty Surgery$283.14M—

Tissue Reconstruction$108.78M—

Other financials

Income statement

See full

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B-56.8%

Enterprise value$3.12B-26.7%

P/S0.8×-1.1×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's total revenue?: Integra LifeSciences (IART) reported total revenue of $391.92M in Q1 2026.
How has Integra LifeSciences's total revenue changed year-over-year?: Integra LifeSciences's total revenue increased by 2.4% year-over-year, from $382.65M to $391.92M.
What is the long-term trend for Integra LifeSciences's total revenue?: Over 4 years (2021 to 2025), Integra LifeSciences's total revenue has grown at a 1.5% compound annual growth rate (CAGR), from $1.54B to $1.64B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.